acc01451 |
Heterogeneous nuclear ribonucleoprotein K |
phosphorylation |
Ser216 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01452 |
Transformer-2 protein homolog beta |
phosphorylation |
Ser264 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01453 |
Transformer-2 protein homolog alpha |
phosphorylation |
Ser260 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01454 |
Nucleolar protein 14 |
phosphorylation |
Ser148 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01455 |
Microtubule-associated protein 1A |
phosphorylation |
Ser1218 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01456 |
Vacuolar fusion protein CCZ1 homolog |
phosphorylation |
Ser266 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01457 |
Vacuolar fusion protein CCZ1 homolog B |
phosphorylation |
Ser266 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01458 |
RNA-binding protein 10 |
phosphorylation |
Ser736 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01459 |
RNA-binding protein 10 |
phosphorylation |
Ser738 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01460 |
Vigilin |
phosphorylation |
Ser31 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01461 |
Heat shock factor protein 1 |
phosphorylation |
Ser363 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01462 |
"Spectrin beta chain, non-erythrocytic 1" |
phosphorylation |
Ser2102 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01463 |
Serine/arginine-rich splicing factor 2 |
phosphorylation |
Ser212 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01464 |
Serine/arginine-rich splicing factor 2 |
phosphorylation |
Ser191 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01465 |
DNA topoisomerase 2-beta |
phosphorylation |
Ser1522 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01466 |
A-kinase anchor protein 12 |
phosphorylation |
Ser381 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01467 |
A-kinase anchor protein 12 |
phosphorylation |
Ser627 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01468 |
Protein ENL |
phosphorylation |
Ser359 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01469 |
CCAAT/enhancer-binding protein zeta |
phosphorylation |
Ser629 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01470 |
Tyrosine-protein phosphatase non-receptor type 12 |
phosphorylation |
Ser673 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01471 |
Serine/arginine-rich splicing factor 11 |
phosphorylation |
Ser434 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01472 |
Neuroblast differentiation-associated protein AHNAK |
phosphorylation |
Ser135 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01473 |
Nuclear pore complex protein Nup160 |
phosphorylation |
Ser1157 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01474 |
General transcription factor 3C polypeptide 1 |
phosphorylation |
Ser1854 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01475 |
General transcription factor 3C polypeptide 1 |
phosphorylation |
Ser739 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01476 |
Nucleosome-remodeling factor subunit BPTF |
phosphorylation |
Ser1300 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01477 |
Chromodomain-helicase-DNA-binding protein 3 |
phosphorylation |
Ser73 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01478 |
TP53-binding protein 1 |
phosphorylation |
Ser1426 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01479 |
TP53-binding protein 1 |
phosphorylation |
Ser1678 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01480 |
TP53-binding protein 1 |
phosphorylation |
Ser1114 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01481 |
TP53-binding protein 1 |
phosphorylation |
Ser1462 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01482 |
Ankyrin-3 |
phosphorylation |
Ser1459 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01483 |
Cell division cycle protein 16 homolog |
phosphorylation |
Ser560 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01484 |
Serine/threonine-protein kinase 4 |
phosphorylation |
Ser320 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01485 |
Acetyl-CoA carboxylase 1 |
phosphorylation |
Ser29 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01486 |
Serine/threonine-protein kinase PAK 1 |
phosphorylation |
Ser174 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01487 |
Chromobox protein homolog 3 |
phosphorylation |
Ser93 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01488 |
Probable ATP-dependent RNA helicase DDX10 |
phosphorylation |
Ser780 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01489 |
S-phase kinase-associated protein 2 |
phosphorylation |
Ser75 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01490 |
Peptidyl-prolyl cis-trans isomerase G |
phosphorylation |
Ser687 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01491 |
Treacle protein |
phosphorylation |
Ser1350 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01492 |
Treacle protein |
phosphorylation |
Ser1228 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01493 |
Splicing factor 3B subunit 2 |
phosphorylation |
Ser309 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01494 |
Golgin subfamily A member 4 |
phosphorylation |
Ser266 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01495 |
Sequestosome-1 |
phosphorylation |
Ser272 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01496 |
Serine/threonine-protein kinase PRP4 homolog |
phosphorylation |
Ser32 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01497 |
Serine/threonine-protein kinase PRP4 homolog |
phosphorylation |
Ser277 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Negative |
4.0 (Moderate) |
PXD000861
|
acc01498 |
Serine/threonine-protein kinase PRP4 homolog |
phosphorylation |
Ser580 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01499 |
Serine/threonine-protein kinase PRP4 homolog |
phosphorylation |
Ser518 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|
acc01500 |
Serine/threonine-protein kinase PRP4 homolog |
phosphorylation |
Ser519 |
human |
Lung Cancer |
PC9IR |
Gefitinib |
Positive |
4.0 (Moderate) |
PXD000861
|